Adapalene

Retinoid (Third Generation)

Also known as: 6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid, CD-271

Description

Adapalene is a third-generation synthetic retinoid that selectively binds to RARβ and RARγ receptors. It offers similar efficacy to tretinoin with improved photostability and tolerability. [Thiboutot 2007]

Mechanism of Action

Selectively binds to nuclear retinoic acid receptors RARβ and RARγ, modulating cellular differentiation and keratinization. Inhibits AP-1 factor and toll-like receptor-mediated inflammatory pathways. More photostable and less irritating than tretinoin. [Shalita 1996]

Indications

Available Concentrations

0.1%0.3%

Side Effects

Contraindications

  • Pregnancy [Zaenglein]
  • Eczematous skin at application site
  • Sunburned skin

Pregnancy Category

C [Zaenglein 2016]

Found In

Drugs containing Adapalene

Cosmetics containing Adapalene

Related Conditions

References

  1. Shalita AR, Weiss JS, Chalker DK, et al. "A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris." J Am Acad Dermatol, 1996. doi:10.1016/S0190-9622(96)90753-6
  2. Thiboutot D, Pariser DM, Egan N, et al. "Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial." J Am Acad Dermatol, 2007. doi:10.1016/j.jaad.2006.10.005
  3. Zaenglein AL, Pathy AL, Schlosser BJ, et al. "Guidelines of care for the management of acne vulgaris." J Am Acad Dermatol, 2016. doi:10.1016/j.jaad.2015.12.037

Limitations

This page provides a general overview of Adapalene in dermatology. It does not cover every possible use, formulation, or interaction. Individual responses to compounds vary — what works for one person may not work for another. Always consult a qualified dermatologist before starting or changing any treatment.